-- Due to the ever-increasing number of requests for precision tools used in immunotherapy research, Creative Biolabs has responded by launching a suite of advanced product options to support and strengthen the development of next-generation immune-based therapies.
Hemolysis Assay for Solutes: A New Benchmark for Complement Activation Study
Complement activation is a key safety and efficacy process for therapeutic agents, in particular, unwanted immune responses associated with monoclonal antibodies, liposomes, and nanoparticles. Creative Biolabs' hemolysis assay for solutes demonstrates a versatile and cost-effective preclinical 2×96-well high-throughput format hemolysis assay for assessing complement-mediated hemolysis across multiple species. It is an excellent option for screening solutes that trigger unwanted immune responses, providing hematology researchers with reliable hemolysis data to pursue formulating and dosing adjustments.
Double Emulsion Droplet Chip: Microfluidics for Precision Encapsulation
Microfluidic technologies are changing how scientists are able to manipulate cells, reagents, and biomolecules at the microscale. The double emulsion droplet chip from Creative Biolabs uses a flow-focusing design and localized surface modifications to create double emulsion droplets with a very uniform structure.
"The chip is made from glass for durability, and it is also able to function at high pressure and at high temperatures, allowing it to be used to encapsulate immune cells, build microreactors, and facilitate single-cell assays. The chip nozzle sizes can be customized; it also works with many surfactants."
So researchers can use this technology to offer control and reproducibility that enables the investigation of novel drug delivery models, synthetic biology systems, and cell-based assays.
Human Alveolar Macrophages: A Physiology-Relevant Model of Innate Immunity
Understanding how macrophages participate in immune regulation, inflammation, and tissue homeostasis is a crucial aspect of developing effective immunotherapies. So, they now offer isolated human alveolar macrophages. These cells are isolated from the lungs of healthy donors and pathogen-tested.
"Researchers are paying more and more attention to human alveolar macrophages in developing new treatments. They're being used in things like drug delivery and immune system therapies, which could really help fight serious lung infections and boost overall lung health," said a scientist.
Driving Innovation in Immunotherapy Research
The new product line reflects their commitment to empowering researchers using scientifically independent, human-relevant, and engineered solutions, which will enable researchers to develop therapeutics faster, safer, and more effectively.
For detailed product and custom services information, visit https://www.creative-biolabs.com/complement-therapeutics/.
About Creative Biolabs
Creative Biolabs is dedicated to improving immunotherapy research and exploring innovative technologies to enable deeper discovery, greater experimental precision, and increased speed-to-discovery for the immune sciences.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: Shirley, NY 11967, USA
Phone: 6318306441
Website: https://www.creative-biolabs.com/complement-therapeutics/
Release ID: 89169850
Google
RSS